CardioFocus Illuminates Underserved “AF-Alone” Market With Light Ring
This article was originally published in The Gray Sheet
Executive Summary
CardioFocus expects its Light Ring catheter to be among the first devices to cure drug-resistant paroxysmal atrial fibrillation (AF) in patients not indicated for surgery